Merck: US drug firm Merck says existing Trump tariffs will cost it $200m this year
The US pharmaceutical company Merck has said it expects to pay an extra $200m (£150m) in costs this year from tariffs that Donald Trump has already imposed, including his 10% tax on imports from around the world.... This data comes from the ChinaPulse.com media intelligence and smart news insights monitoring platform.
Read full article »
Merck is a New Jersey-based multinational biopharmaceutical company that develops and commercializes novel therapeutics and vaccines for the treatment of a range of diseases.
Read more